1 study on Pgp curated from PubMed, ClinicalTrials.gov, and EuropePMC. Updated daily.
Bottom line: TitrateLab currently curates 1 dated study on Pgp. The source summaries below describe published research; they do not establish product quality, safety, or clinical suitability.
**Semax's superiority over PGP under ischemia** suggests the N-terminal portion of the molecule — beyond the shared PGP tripeptide — contributes critical neuroprotective properties that cannot be reduced to its C-end …
Free, no account — handy when you're working with Pgp.
Pro members save studies and unlock the full evidence breakdown and vendor lab data.
Buyer protection: Wrong or defective product? Report it within 7 days. We broker a refund or reship with the vendor.
$14 monthly or $88/year
Create an account